B. Tang

ORCID: 0000-0002-7644-5247
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Rheumatoid Arthritis Research and Therapies
  • Inflammatory Bowel Disease
  • Health Systems, Economic Evaluations, Quality of Life
  • Microscopic Colitis
  • Psoriasis: Treatment and Pathogenesis
  • Healthcare Systems and Reforms
  • Biosimilars and Bioanalytical Methods
  • Pharmaceutical studies and practices
  • Global Health Care Issues
  • Adolescent and Pediatric Healthcare
  • Spondyloarthritis Studies and Treatments
  • Healthcare Policy and Management
  • Chronic Lymphocytic Leukemia Research
  • Diverticular Disease and Complications
  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Eosinophilic Esophagitis
  • Bacterial Identification and Susceptibility Testing
  • Dermatology and Skin Diseases
  • Technology and Data Analysis
  • Autoimmune and Inflammatory Disorders Research
  • Dementia and Cognitive Impairment Research
  • Neutropenia and Cancer Infections
  • Systemic Lupus Erythematosus Research
  • Acute Lymphoblastic Leukemia research

Peking University People's Hospital
2024

Peking University
2024

Tianjin Normal University
2024

Nanchang Normal University
2023

Teva Pharmaceuticals (United States)
2015

Pfizer (United States)
2012-2014

Ortho Clinical Diagnostics (United States)
2008

Janssen (United States)
2007

Health Outcomes Solutions (United States)
2006

This study assessed the effects of adding tislelizumab to first-line standard-of- care chemotherapy on health-related quality life (HRQoL) patients with advanced squamous non-small cell lung cancer (sq-NSCLC).Patients in this open-label, multicenter, phase 3 RATIONALE 307 trial were randomized one three arms: plus carboplatin and paclitaxel (Arm A), nab-paclitaxel B), or C). HRQoL was measured using European Organization for Research Treatment Cancer (EORTC) Quality Life Questionnaire Core...

10.1016/j.ctarc.2021.100501 article EN cc-by-nc-nd Cancer Treatment and Research Communications 2021-12-17

To evaluate the efficacy and safety of matched sibling donor allogeneic hematopoietic stem cell transplantation (allo-HSCT) for treatment myelofibrosis (MF).

10.3760/cma.j.cn112138-20240409-00225 article EN PubMed 2024-10-01

Psoriasis is a chronic, inflammatory and autoimmune disease that occurs in the skin causes flaking, swollen pain. In Colombia there are no official reports on burden of psoriasis. The aim this study was to estimate prevalence psoriasis Colombians (children adults) its associated costs private public settings.

10.1016/j.jval.2013.03.558 article EN publisher-specific-oa Value in Health 2013-05-01

Hepatosplenic candidiasis (HSC) is a rare type of that can occur in patients with hematologic malignancies, hematopoietic stem cell transplantation. At present, there still lack studies on HSC disorders. Based The Chinese Guidelines for the Diagnosis and Treatment Invasive Fungal Disease Patients Hematological Disorders Cancers (the 6th revision), We retrospectively analyzed clinical characteristics prognosis treated Peking University Institute Hematology from 2008 to 2022. Finally, eighteen...

10.3760/cma.j.cn121090-20231230-00347 article EN PubMed 2024-07-14

Some psoriasis patients also have psoriatic arthritis (PsA), which increases disease burden and further reduces quality-of-life (QoL). Our objective was to compare QoL of subjects with both PsA those alone, evaluate improvement on etanercept (ETN) therapy in specific countries Central Eastern Europe, Latin America, Asia where data are limited. Patients moderate/severe were randomized 50mg ETN QW (once weekly) or BIW (twice weekly, weeks 1-12), followed by (weeks 13-24). The following...

10.1016/j.jval.2013.08.1184 article EN publisher-specific-oa Value in Health 2013-10-22

Purpose: To assess the impact of maintenance versus episodic infliximab therapy on hospitalizations and surgery in patients with Crohn's disease (CD). Methods: A retrospective analysis claims data was conducted from Marketscan Commercial Claims Encounters database 2000 to 2003 for claimants CD (ICD-9 codes, 555.0, 555.1, 555.2 or 555.9) who had an induction regimen (3 infusions) 2003. Continuous enrollment 12-months pre post index infusion date required. Patients were excluded if they...

10.14309/00000434-200709002-00864 article EN The American Journal of Gastroenterology 2007-09-01

To provide a cost-efficacy (CE) analysis of achieving remission in Crohn's disease (CD) patients following treatment with infliximab or certolizumab pegol from payer perspective. An Excel-based CE model was developed to estimate cost per successful CD using published data for and pegol. Dosing information obtained the product labels. Drug costs were First Databank April 2008 wholesale acquisition (WAC). The one 100mg vial $604, 200mg syringe $658. medical infusions estimated be $237 infusion...

10.1097/00054725-200812003-00124 article EN Inflammatory Bowel Diseases 2008-12-01

10.1016/j.jval.2014.03.1682 article EN publisher-specific-oa Value in Health 2014-05-01

<h3>Background</h3> Whilst studies addressing the burden of rheumatoid arthritis (RA) in both developed and developing countries have been published, there is limited information available comparing these environments. <h3>Objectives</h3> To evaluate compare RA emerging countries. <h3>Methods</h3> Data were analysed from 2011 2012 National Health Wellness Survey an annual cross-sectional survey conducted 5 European Union (5EU: France, Germany, Italy, Spain, UK), Japan, US, Brazil, urban...

10.1136/annrheumdis-2014-eular.4241 article EN Annals of the Rheumatic Diseases 2014-06-01

Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid (AML) with approximately 1,000 to 1,500 new cases diagnosed each year in the United States (US). Trisenox (arsenic trioxide, ATO) currently licensed for treatment patients APL who are refractory to, or have relapsed from previous all-trans retinoic acid (ATRA) and anthracycline-based chemotherapy. This analysis evaluated cost-effectiveness ATO+ATRA newly low-to-intermediate risk adult patients, compared two other...

10.1016/j.jval.2015.03.1170 article EN publisher-specific-oa Value in Health 2015-05-01

Red archives constitute a significant part of archival resources, bearing unique significance for information retention and emotional transmission. In various social practices, red provide crucial resource support exhibit diversified forms value. diverse utilization activities, demonstrate evidential value in testifying history, educational reinforcing education, carrying forward the spirit predecessors. The realization depends on needs subjects process practice activities. We need to carry...

10.23977/infkm.2023.040504 article EN cc-by Information and Knowledge Management 2023-01-01

Red archives constitute a significant part of archival resources, bearing unique significance for information retention and emotional transmission. In various social practices, red provide crucial resource support exhibit diversified forms value. diverse utilization activities, demonstrate evidential value in testifying history, educational reinforcing education, carrying forward the spirit predecessors. The realization depends on needs subjects process practice activities. We need to carry...

10.23977/infkm.2023.040414 article EN cc-by Information and Knowledge Management 2023-01-01

<h3>Background</h3> The risk of tuberculosis (TB), infection and lymphoma is a major concern for anti-tumor necrosis factor (anti-TNF) therapies. However, limited comparative data about the rates in Asia Taiwan <h3>Objectives</h3> To assess incidence TB, serious bacterial rheumatoid arthritis patients who received anti-TNF therapy non-biologic treatment Taiwan. <h3>Methods</h3> National Health Insurance Research Database (NHIRD) 1999-2009 were analyzed. NHIRD comprises longitudinal...

10.1136/annrheumdis-2012-eular.3430 article EN Annals of the Rheumatic Diseases 2013-06-01
Coming Soon ...